학술논문

Population-based study of the durability of humoral immunity after SARS-CoV-2 infection
Document Type
article
Source
Frontiers in Immunology, Vol 14 (2023)
Subject
SARS-CoV-2
COVID-19
longitudinal
durability
population-based
antibody
Immunologic diseases. Allergy
RC581-607
Language
English
ISSN
1664-3224
Abstract
SARS-CoV-2 antibody quantity and quality are key markers of humoral immunity. However, there is substantial uncertainty about their durability. We investigated levels and temporal change of SARS-CoV-2 antibody quantity and quality. We analyzed sera (8 binding, 4 avidity assays for spike-(S-)protein and nucleocapsid-(N-)protein; neutralization) from 211 seropositive unvaccinated participants, from the population-based longitudinal TiKoCo study, at three time points within one year after infection with the ancestral SARS-CoV-2 virus. We found a significant decline of neutralization titers and binding antibody levels in most assays (linear mixed regression model, p